Postes actifs de Elmar Schärli
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
Xigen SA
 Xigen SA Pharmaceuticals: MajorHealth Technology Xigen SA develops intracellular peptide therapeutics for the treatment of stroke, myocardial infarction and cancer. It focuses on the acute or short-term treatment of major debilitating pathologies that underly unmet medical needs plaguing humanity. The company was founded in 2002 and is headquartered in Epalinges, Switzerland. | Directeur Financier/CFO | - | - |
Zilentin AG
 Zilentin AG Pharmaceuticals: MajorHealth Technology Zilentin AG develops projects for the treatment of tinnitus and hearing loss. The company is headquartered in Zug, Switzerland. | Directeur/Membre du Conseil | - | - |
Historique de carrière de Elmar Schärli
Anciens postes connus de Elmar Schärli
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| ALTAMIRA THERAPEUTICS LTD. | Directeur Financier/CFO | 01/11/2019 | 01/11/2021 |
Statistiques
Internationale
| Suisse | 3 |
| Bermudes | 2 |
Opérationnelle
| Director of Finance/CFO | 2 |
| Director/Board Member | 1 |
Sectorielle
| Health Technology | 4 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| ALTAMIRA THERAPEUTICS LTD. | Health Technology |
| Entreprise privées | 2 |
|---|---|
Xigen SA
Xigen SA Pharmaceuticals: MajorHealth Technology Xigen SA develops intracellular peptide therapeutics for the treatment of stroke, myocardial infarction and cancer. It focuses on the acute or short-term treatment of major debilitating pathologies that underly unmet medical needs plaguing humanity. The company was founded in 2002 and is headquartered in Epalinges, Switzerland. | Health Technology |
Zilentin AG
Zilentin AG Pharmaceuticals: MajorHealth Technology Zilentin AG develops projects for the treatment of tinnitus and hearing loss. The company is headquartered in Zug, Switzerland. | Health Technology |
- Bourse
- Insiders
- Elmar Schärli
- Expérience
